Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Voices From TCT 2015: Ken Stein On The Future Of Watchman

This article was originally published in The Gray Sheet

Executive Summary

In an exclusive podcast interview with "The Gray Sheet," Ken Stein, Boston Scientific's chief medical officer for cardiac rhythm management, says the company is well positioned to expand adoption of its novel Watchman left-atrial appendage closure device after a challenging regulatory process. He says CMS' recent denial of a new-technology add-on payment is actually good news for the device and the company is looking forward to that agency establishing a national coverage policy.

Advertisement

Related Content

Boston Sci's Watchman Gets Positive Medicare Coverage Policy
Boston Sci's Watchman Gets Positive Medicare Coverage Policy
CMS Proposes CED Policy For Watchman With Some Unexpected Conditions
Drug-Coated Balloons Net Medicare Inpatient Bonus Payments
National Medicare Analysis Opened For Watchman Device
Boston Sci’s Watchman Stroke Device Finally Lands FDA Approval, With Favorable Labeling

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT034312

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel